2014-2026 Global Cystic Fibrosis Therapeutics Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID : Maia-15086686 | Publishing Date : 14-Jan-2020 | No. of pages : 106
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
ProQR Therapeutics
Alcresta Therapeutics
Pharmaxis
AstraZeneca
Insmed Incorporated
PTC Therapeutics
Novartis
Cyclacel Pharmaceuticals
F. Hoffmann-La Roche
Vectura
Savara
Celtaxsys
Vertex Pharmaceuticals
Gilead Sciences
AbbVie
Bayer
Allergan
Major Types Covered
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Major Applications Covered
Hospitals
Clinics
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region